| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |